Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 230 participants.
Also called NCT02689180
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 230 participants
- Sponsor
- Registry
-
NCT02689180
-
- Other papers using this trial's data
- Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT02689180. Randomized; quadruple masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients
- Acronym
- ReBIC-1
- Condition
- Heart Failure
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Furosemide
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Collaborator
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Record details
- Record id
cardio:ct-nct02689180- Content hash
f56f5a1e22e4fea5d111d14fc7323ecf4845e982c492ed10944b92500b560aed